KELLY FENDLEY: Open Payments
NPI 1861832628 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$728 in 46 payments from 16 companies in 2025. Trend: 2023 $241 · 2024 $484 · 2025 $728
Food & beverage: $728
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $200 |
| ABBVIE INC. | 16 | $174 |
| Novo Nordisk Inc | 4 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Amgen Inc. | 3 | $43 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Korlym, VRAYLAR, UBRELVY, Rybelsus, AIRSUPRA, MOUNJARO, ELIQUIS, OTEZLA.
Industry payments across GA — which companies pay providers there.
